Bruker (BRKR) Financials

$36.45 -1.74 (-4.56%)

Closing price 04:00 PM Eastern

Extended Trading

$35.98 -0.47 (-1.30%)

As of 07:56 PM Eastern

Annual Income Statements for Bruker

This table shows Bruker's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	113	427	297	277	158	197	180	79	154	102
Consolidated Net Income / (Loss)	114	429	299	281	161	198	181	80	155	105
Net Income / (Loss) Continuing Operations	114	429	299	281	161	499	181	80	155	105
Total Pre-Tax Income	207	544	414	394	226	280	245	198	178	128
Total Operating Income	253	437	433	413	248	301	262	220	182	146
Total Gross Profit	1,650	1,513	1,306	1,210	940	995	900	816	745	709
Total Revenue	3,366	2,965	2,531	2,418	1,988	4,145	1,896	1,766	1,611	1,624
Operating Revenue	3,366	2,965	2,531	2,418	1,988	4,145	1,896	1,766	1,611	1,617
Total Cost of Revenue	1,717	1,451	1,225	1,208	1,048	2,155	996	950	866	915
Operating Cost of Revenue	1,717	1,451	1,225	1,208	-	2,155	996	950	866	915
Total Operating Expenses	1,396	1,076	873	796	692	1,389	638	597	564	563
Selling, General & Admin Expense	894	729	607	561	469	500	445	415	390	392
Research & Development Expense	377	295	236	221	198	188	173	162	148	146
Other Special Charges / (Income)	126	52	30	14	25	6.50	20	20	26	25
Total Other Income / (Expense), net	-46	107	-19	-20	-23	-21	-18	-22	-4.20	-18
Other Income / (Expense), net	-46	107	-19	-20	-23	-21	-18	-22	-4.20	-18
Income Tax Expense	91	118	116	113	64	82	64	118	23	23
Other Gains / (Losses), net	-1.70	2.00	1.00	0.00	0.00	-	-	-	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	0.70	1.30	1.90	3.50	3.60	0.80	1.30	1.70	0.90	3.30
Basic Earnings per Share	$0.76	$2.92	$2.00	$1.83	$1.03	$1.27	$1.15	$0.50	$0.95	$0.60
Weighted Average Basic Shares Outstanding	149M	146.40M	148.60M	151.40M	153.40M	155.20M	156.20M	158.10M	161.40M	168.20M
Diluted Earnings per Share	$0.76	$2.90	$1.99	$1.81	$1.02	$1.26	$1.14	$0.49	$0.95	$0.60
Weighted Average Diluted Shares Outstanding	149.50M	147.20M	149.40M	152.90M	154.60M	156.60M	157.20M	159.10M	162.20M	169.10M
Weighted Average Basic & Diluted Shares Outstanding	151.71M	137.67M	146.73M	150.77M	151.57M	155.30M	156.30M	157.20M	161.70M	169.30M
Cash Dividends to Common per Share	$0.20	$0.20	$0.20	$0.16	$0.16	$300,000.00	$0.00	$0.00	$0.16	-

This table shows Bruker's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	17	14	41	7.60	51	206	88	57	77	97	88
Consolidated Net Income / (Loss)	17	14	40	7.60	52	205	89	58	77	98	88
Net Income / (Loss) Continuing Operations	17	14	40	7.60	52	205	89	58	77	98	88
Total Pre-Tax Income	25	56	55	24	72	241	119	78	107	121	129
Total Operating Income	32	72	68	48	65	104	125	86	123	131	131
Total Gross Profit	391	493	419	385	353	430	383	341	360	366	335
Total Revenue	801	980	864	801	722	855	743	682	685	708	639
Operating Revenue	801	980	864	801	722	855	743	682	685	708	639
Total Cost of Revenue	410	486	446	416	369	424	360	341	326	343	304
Operating Cost of Revenue	410	486	446	416	369	424	360	341	326	-	304
Total Operating Expenses	359	421	351	337	288	327	258	254	237	235	204
Selling, General & Admin Expense	225	247	230	221	195	211	178	178	163	165	145
Research & Development Expense	97	104	98	92	82	84	71	71	69	64	56
Other Special Charges / (Income)	37	70	23	23	11	32	9.40	5.40	5.30	6.70	3.00
Total Other Income / (Expense), net	-6.70	-16	-13	-24	6.80	137	-5.30	-8.70	-16	-10	-2.00
Other Income / (Expense), net	-6.70	-16	-13	-24	6.80	137	-5.30	-8.70	-16	-10	-2.00
Income Tax Expense	8.70	41	15	16	20	37	31	20	30	23	41
Other Gains / (Losses), net	0.40	-1.50	-0.20	-0.20	0.20	0.80	0.30	0.20	0.70	-	0.30
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.60	0.20	-0.60	0.00	1.10	-0.90	0.60	0.70	0.90	0.90	0.30
Basic Earnings per Share	$0.11	$0.09	$0.27	$0.05	$0.35	$1.41	$0.60	$0.39	$0.52	$0.66	$0.60
Weighted Average Basic Shares Outstanding	151.60M	149M	151.50M	147.40M	145.20M	146.40M	146.60M	146.80M	146.80M	148.60M	147.80M
Diluted Earnings per Share	$0.11	$0.09	$0.27	$0.05	$0.35	$1.39	$0.60	$0.39	$0.52	$0.66	$0.59
Weighted Average Diluted Shares Outstanding	151.90M	149.50M	152M	148M	145.90M	147.20M	147.30M	147.70M	147.60M	149.40M	148.60M
Weighted Average Basic & Diluted Shares Outstanding	151.53M	151.71M	151.60M	151.39M	145.34M	137.67M	138.41M	146.85M	146.73M	146.73M	147.08M
Cash Dividends to Common per Share	$0.05	-	$0.05	$0.05	$0.05	-	$0.05	$0.05	$0.05	-	$0.05

This table details how cash moves in and out of Bruker's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-305	-157	-423	386	3.60	356	3.90	-17	75	-54
Net Cash From Operating Activities	251	350	274	282	332	213	240	154	131	229
Net Cash From Continuing Operating Activities	251	350	274	282	332	213	240	154	131	229
Net Income / (Loss) Continuing Operations	114	429	299	281	161	198	181	80	155	105
Consolidated Net Income / (Loss)	114	429	299	281	161	198	181	80	155	105
Depreciation Expense	184	115	89	89	80	76	65	64	54	53
Non-Cash Adjustments To Reconcile Net Income	96	-81	46	44	43	20	51	-5.20	34	54
Changes in Operating Assets and Liabilities, net	-142	-112	-159	-131	47	-80	-57	15	-112	17
Net Cash From Investing Activities	-1,757	-326	-252	-192	-193	-158	-123	-30	-22	-102
Net Cash From Continuing Investing Activities	-1,757	-326	-252	-192	-193	-158	-123	-30	-22	-102
Purchase of Property, Plant & Equipment	-115	-107	-129	-92	-97	-73	-49	-44	-37	-34
Acquisitions	-1,600	-227	-182	-65	-59	-90	-192	-66	-24	-29
Purchase of Investments	-48	-25	-60	-149	-151	-6.40	0.00	-119	-127	-159
Sale of Property, Plant & Equipment	1.10	11	14	4.90	0.20	11	0.40	12	1.10	0.90
Sale and/or Maturity of Investments	4.80	21	106	108	115	0.00	117	187	165	119
Net Cash From Financing Activities	1,230	-193	-415	319	-162	300	-112	-159	-28	-169
Net Cash From Continuing Financing Activities	1,230	-193	-415	319	-162	300	-112	-159	-28	-169
Repayment of Debt	-1,354	-24	-111	-0.10	-305	-386	-223	-151	-0.10	-130
Repurchase of Common Equity	0.00	-152	-263	-153	-123	-142	0.00	-152	-160	-90
Payment of Dividends	-45	-26	-42	-24	-26	-25	-26	-26	-27	-1.30
Issuance of Debt	2,224	2.00	0.30	490	297	849	129	154	146	42
Issuance of Common Equity	409	9.50	2.80	7.00	3.30	11	9.40	20	12	11
Other Financing Activities, net	-4.70	-2.70	-2.70	-0.40	-7.50	-6.20	-2.30	-3.50	1.20	-0.80
Effect of Exchange Rate Changes	-29	12	-31	-23	26	0.60	-	18	-6.40	-11
Cash Interest Paid	55	34	24	20	29	16	12	15	13	12
Cash Income Taxes Paid	154	97	147	146	43	61	61	53	72	57

This table details how cash moves in and out of Bruker's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	1.00	35	-22	-170	-148	125	-211	-23	-47	19	-97
Net Cash From Operating Activities	65	190	38	1.10	22	206	44	13	88	172	70
Net Cash From Continuing Operating Activities	65	190	38	1.10	22	206	44	13	88	172	70
Net Income / (Loss) Continuing Operations	17	14	40	7.60	52	205	89	58	77	98	88
Consolidated Net Income / (Loss)	17	14	40	7.60	52	205	89	58	77	98	88
Depreciation Expense	50	53	51	45	35	37	27	26	25	25	21
Non-Cash Adjustments To Reconcile Net Income	11	52	16	27	0.60	-121	9.40	21	8.60	11	13
Changes in Operating Assets and Liabilities, net	-13	71	-69	-79	-66	84	-81	-92	-24	38	-53
Net Cash From Investing Activities	-26	-61	-68	-1,325	-304	-37	-155	-26	-108	-149	-58
Net Cash From Continuing Investing Activities	-26	-61	-68	-1,325	-304	-37	-155	-26	-108	-149	-58
Purchase of Property, Plant & Equipment	-26	-37	-33	-25	-21	-32	-27	-24	-25	-35	-58
Acquisitions	-1.10	-23	-0.20	-1,302	-275	-4.30	-120	-15	-88	-97	-0.10
Other Investing Activities, net	1.00	-	-	-	-	-	-	-	-	-	-
Net Cash From Financing Activities	-51	-75	-2.70	1,156	152	-60	-93	-10	-31	-36	-82
Net Cash From Continuing Financing Activities	-51	-75	-2.70	1,156	152	-60	-93	-10	-31	-36	-82
Repayment of Debt	-177	-243	-155	-848	-109	-17	-2.50	-2.40	-2.10	-4.80	-0.20
Repurchase of Common Equity	-10	-	-	-	0.00	-50	-80	-	-22	-26	-71
Payment of Dividends	-7.70	-21	-7.60	-7.80	-8.20	-7.80	-8.90	-7.60	-2.10	-8.60	-11
Issuance of Debt	143	1,157	-3.00	805	265	10	-3.40	-4.70	0.00	0.30	-0.10
Issuance of Common Equity	0.40	3.20	-2.80	405	3.40	4.70	2.00	2.10	0.70	2.00	-2.50
Effect of Exchange Rate Changes	13	-19	10	-2.10	-18	16	-7.90	0.10	4.10	33	-27

This table presents Bruker's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	5,807	4,250	3,612	3,650	3,049	2,772	2,129	1,949	1,808	1,730
Total Current Assets	2,053	2,164	2,113	2,472	1,925	1,796	1,304	1,359	1,276	1,232
Cash & Equivalents	183	488	646	1,068	682	678	322	325	342	267
Accounts Receivable	566	492	473	417	335	362	357	319	244	235
Inventories, net	1,068	968	800	710	692	577	510	486	440	422
Other Current Assets	237	216	195	177	166	172	115	114	91	107
Plant, Property, & Equipment, net	669	600	487	406	396	306	271	267	239	231
Total Noncurrent Assets	3,084	1,486	1,012	772	729	669	554	323	293	267
Goodwill	1,507	583	458	340	320	293	276	170	131	131
Intangible Assets	913	331	271	212	229	233	219	82	70	75
Noncurrent Deferred & Refundable Income Taxes	286	297	77	90	72	61	51	57	77	53
Other Noncurrent Operating Assets	378	276	206	131	107	82	8.40	14	17	9.10
Total Liabilities & Shareholders' Equity	5,807	4,250	3,612	3,650	3,049	2,772	2,129	1,949	1,808	1,730
Total Liabilities	3,992	2,837	2,480	2,565	2,075	1,833	1,201	1,215	1,115	997
Total Current Liabilities	1,281	1,202	914	939	792	646	599	525	525	555
Short-Term Debt	33	121	19	112	2.20	0.50	19	-	20	0.60
Accounts Payable	234	203	178	147	135	118	105	91	86	72
Current Deferred Revenue	438	400	370	198	189	138	124	112	149	178
Other Current Liabilities	577	478	347	481	466	389	352	322	270	304
Total Noncurrent Liabilities	2,710	1,635	1,566	1,627	1,283	1,188	602	691	591	443
Long-Term Debt	2,062	1,160	1,201	1,222	842	813	323	416	392	265
Noncurrent Deferred Revenue	100	92	102	50	51	43	-	49	47	44
Noncurrent Deferred & Payable Income Tax Liabilities	119	68	62	46	43	49	51	24	10	9.50
Other Noncurrent Operating Liabilities	430	315	156	204	223	161	137	96	40	32
Commitments & Contingencies	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	18	19	6.10	0.20	0.00	21	23	-	-	-
Total Equity & Noncontrolling Interests	1,797	1,395	1,126	1,085	974	917	905	734	693	733
Total Preferred & Common Equity	1,781	1,377	1,114	1,071	961	907	897	725	686	726
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,781	1,377	1,114	1,071	961	907	897	725	686	726
Common Stock	715	285	258	240	218	201	179	158	126	104
Retained Earnings	2,407	2,324	1,926	1,660	1,407	1,275	1,103	942	885	757
Treasury Stock	-1,237	-1,237	-1,085	-820	-667	-544	-402	-401	-249	-91
Accumulated Other Comprehensive Income / (Loss)	-104	6.00	15	-8.20	3.70	-26	17	27	-76	-44
Noncontrolling Interest	16	17	12	14	13	10	8.50	8.10	6.70	6.80

This table presents Bruker's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	5,933	6,113	5,903	4,506	3,820	3,857	3,764	3,337
Total Current Assets	2,112	2,191	2,153	2,140	2,029	2,183	2,133	2,037
Cash & Equivalents	184	148	170	340	364	575	598	626
Accounts Receivable	538	538	507	475	485	451	472	421
Inventories, net	1,117	1,220	1,176	1,061	916	915	859	750
Other Current Assets	273	285	300	264	264	243	205	240
Plant, Property, & Equipment, net	689	694	657	586	527	523	511	422
Total Noncurrent Assets	3,133	3,228	3,093	1,780	1,263	1,151	1,120	879
Goodwill	2,435	1,475	1,444	752	561	558	527	382
Other Noncurrent Operating Assets	698	386	322	299	410	293	294	283
Total Liabilities & Shareholders' Equity	5,933	6,113	5,903	4,506	3,820	3,857	3,764	3,337
Total Liabilities	4,082	4,270	4,078	3,056	2,575	2,594	2,553	2,383
Total Current Liabilities	1,345	1,322	1,305	1,183	1,072	1,051	1,049	865
Short-Term Debt	38	33	26	21	121	121	120	17
Accounts Payable	245	228	220	199	182	189	196	158
Current Deferred Revenue	471	467	502	485	381	397	398	176
Other Current Liabilities	592	595	556	477	389	344	334	514
Total Noncurrent Liabilities	2,737	2,948	2,774	1,873	1,503	1,544	1,505	1,519
Long-Term Debt	2,076	2,265	2,132	1,357	1,099	1,123	1,109	1,137
Other Noncurrent Operating Liabilities	661	327	290	252	405	421	396	382
Redeemable Noncontrolling Interest	18	18	18	18	17	12	12	5.70
Total Equity & Noncontrolling Interests	1,833	1,825	1,807	1,433	1,227	1,251	1,199	948
Total Preferred & Common Equity	0.00	1,807	1,789	1,415	1,209	1,231	1,180	937
Total Common Equity	0.00	1,807	1,789	1,415	1,209	1,231	1,180	937

This table displays calculated financial ratios and metrics derived from Bruker's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	13.56%	17.14%	4.67%	21.66%	-52.05%	118.67%	7.34%	9.59%	-0.77%	-10.23%
EBITDA Growth	-40.72%	31.11%	4.14%	57.64%	-13.99%	14.99%	18.30%	12.85%	27.91%	12.61%
EBIT Growth	-61.98%	31.48%	5.16%	74.31%	-19.47%	14.59%	23.71%	11.37%	38.75%	26.36%
NOPAT Growth	-58.74%	10.09%	5.56%	66.01%	-16.47%	9.47%	117.81%	-43.66%	32.45%	92.55%
Net Income Growth	-73.44%	43.55%	6.38%	73.85%	-18.48%	9.39%	125.40%	-48.03%	47.28%	76.01%
EPS Growth	-73.79%	45.73%	9.94%	77.45%	-19.05%	10.53%	132.65%	-48.42%	58.33%	81.82%
Operating Cash Flow Growth	-28.22%	27.59%	-2.83%	-14.99%	55.67%	-10.97%	55.25%	18.04%	-42.93%	100.52%
Free Cash Flow Firm Growth	-769.09%	-10.37%	-209.82%	-16.70%	70.23%	317.59%	-160.32%	-119.38%	-61.48%	9.48%
Invested Capital Growth	68.87%	29.38%	36.35%	15.07%	1.91%	12.70%	33.31%	17.44%	13.97%	-15.70%
Revenue Q/Q Growth	3.86%	5.18%	0.99%	2.37%	-34.21%	36.46%	1.23%	3.53%	-0.49%	-1.80%
EBITDA Q/Q Growth	-30.22%	25.21%	0.60%	3.23%	-0.68%	3.70%	4.21%	0.77%	10.32%	15.99%
EBIT Q/Q Growth	-47.18%	28.26%	0.36%	3.63%	-2.38%	4.08%	4.98%	0.10%	13.48%	22.84%
NOPAT Q/Q Growth	-35.99%	-2.33%	8.85%	1.22%	2.03%	-4.56%	79.86%	-43.83%	-1.80%	50.03%
Net Income Q/Q Growth	-62.63%	32.99%	8.07%	1.70%	1.57%	-4.39%	80.82%	-47.31%	4.82%	51.15%
EPS Q/Q Growth	-63.11%	33.64%	9.34%	2.84%	0.00%	-3.82%	80.95%	-47.87%	7.95%	53.85%
Operating Cash Flow Q/Q Growth	-5.81%	10.76%	13.62%	-18.57%	25.17%	1.86%	13.55%	9.12%	-31.01%	53.93%
Free Cash Flow Firm Q/Q Growth	17.53%	40.90%	-378.82%	-40.39%	73.68%	225.25%	-141.01%	-97.39%	-41.57%	9.93%
Invested Capital Q/Q Growth	-6.67%	5.06%	15.14%	0.30%	-7.53%	-2.33%	18.94%	-10.28%	-3.17%	-12.63%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.00%	51.05%	51.59%	50.03%	47.29%	24.01%	47.48%	46.21%	46.25%	43.64%
EBITDA Margin	11.61%	22.23%	19.86%	19.96%	15.41%	8.59%	16.33%	14.82%	14.39%	11.17%
Operating Margin	7.52%	14.74%	17.10%	17.09%	12.49%	7.26%	13.84%	12.43%	11.28%	8.97%
EBIT Margin	6.15%	18.36%	16.36%	16.28%	11.36%	6.76%	12.91%	11.20%	11.02%	7.88%
Profit (Net Income) Margin	3.38%	14.45%	11.80%	11.61%	8.12%	4.78%	9.55%	4.55%	9.59%	6.46%
Tax Burden Percent	55.00%	78.74%	72.12%	71.29%	71.48%	70.61%	73.97%	40.60%	86.99%	81.95%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	44.18%	21.63%	28.12%	28.71%	28.52%	29.39%	26.03%	59.40%	13.01%	18.05%
Return on Invested Capital (ROIC)	4.76%	17.51%	21.04%	25.21%	16.48%	21.11%	23.44%	13.56%	27.87%	20.59%
ROIC Less NNEP Spread (ROIC-NNEP)	2.73%	30.10%	17.66%	15.13%	3.14%	1.43%	557.82%	29.26%	30.38%	29.00%
Return on Net Nonoperating Assets (RNNOA)	2.29%	16.17%	5.89%	2.05%	0.40%	0.11%	-1.65%	-2.30%	-6.20%	-6.65%
Return on Equity (ROE)	7.05%	33.67%	26.93%	27.25%	16.88%	21.22%	21.79%	11.26%	21.67%	13.94%
Cash Return on Invested Capital (CROIC)	-46.47%	-8.11%	-9.72%	11.19%	14.59%	9.17%	-5.12%	-2.48%	14.81%	37.63%
Operating Return on Assets (OROA)	4.11%	13.84%	11.40%	11.75%	7.76%	11.44%	12.00%	10.53%	10.04%	7.12%
Return on Assets (ROA)	2.26%	10.90%	8.22%	8.38%	5.55%	8.08%	8.88%	4.27%	8.73%	5.84%
Return on Common Equity (ROCE)	6.90%	32.96%	26.54%	26.89%	16.49%	20.51%	21.28%	11.14%	21.46%	13.83%
Return on Equity Simple (ROE_SIMPLE)	6.39%	31.11%	26.80%	26.21%	16.79%	21.84%	20.19%	11.07%	22.51%	14.45%
Net Operating Profit after Tax (NOPAT)	141	342	311	295	177	212	194	89	158	119
NOPAT Margin	4.20%	11.55%	12.29%	12.19%	8.93%	5.13%	10.24%	5.05%	9.82%	7.35%
Net Nonoperating Expense Percent (NNEP)	2.03%	-12.60%	3.38%	10.08%	13.34%	19.68%	-534.38%	-15.70%	-2.51%	-8.41%
Return On Investment Capital (ROIC_SIMPLE)	3.63%	12.80%	13.26%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	51.00%	48.95%	48.41%	49.97%	52.71%	51.98%	52.52%	53.79%	53.75%	56.36%
SG&A Expenses to Revenue	26.55%	24.60%	24.00%	23.21%	23.58%	12.07%	23.46%	23.51%	24.19%	24.15%
R&D to Revenue	11.18%	9.94%	9.32%	9.13%	9.96%	4.53%	9.15%	9.15%	9.18%	8.97%
Operating Expenses to Revenue	41.48%	36.31%	34.50%	32.93%	34.79%	33.50%	33.64%	33.78%	34.97%	34.67%
Earnings before Interest and Taxes (EBIT)	207	544	414	394	226	280	245	198	178	128
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	391	659	503	483	306	356	310	262	232	181
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.99	7.36	8.97	11.80	8.54	8.54	5.11	7.20	4.82	5.42
Price to Tangible Book Value (P/TBV)	0.00	21.85	25.94	24.33	19.94	20.35	11.40	11.04	6.80	7.56
Price to Revenue (P/Rev)	2.64	3.42	3.95	5.22	4.13	1.87	2.42	2.96	2.05	2.43
Price to Earnings (P/E)	78.57	23.74	33.70	45.58	52.02	39.28	25.51	66.46	21.52	38.76
Dividend Yield	0.34%	0.27%	0.29%	0.19%	0.30%	0.32%	0.55%	0.48%	0.78%	0.00%
Earnings Yield	1.27%	4.21%	2.97%	2.19%	1.92%	2.55%	3.92%	1.50%	4.65%	2.58%
Enterprise Value to Invested Capital (EV/IC)	2.91	4.97	6.21	10.24	7.67	7.41	4.90	7.34	5.33	7.06
Enterprise Value to Revenue (EV/Rev)	3.22	3.70	4.18	5.30	4.19	1.91	2.44	2.95	2.00	2.30
Enterprise Value to EBITDA (EV/EBITDA)	27.72	16.64	21.06	26.54	27.22	22.21	14.96	19.90	13.90	20.64
Enterprise Value to EBIT (EV/EBIT)	52.35	20.16	25.58	32.55	36.91	28.20	18.93	26.33	18.15	29.24
Enterprise Value to NOPAT (EV/NOPAT)	76.66	32.04	34.04	43.48	46.96	37.21	23.87	58.45	20.38	31.34
Enterprise Value to Operating Cash Flow (EV/OCF)	43.10	31.33	38.58	45.37	25.09	37.05	19.33	33.73	24.64	16.33
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	97.91	53.06	85.68	0.00	0.00	38.35	17.15
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.15	0.91	1.08	1.23	0.87	0.87	0.37	0.57	0.59	0.36
Long-Term Debt to Equity	1.14	0.82	1.06	1.13	0.86	0.87	0.35	0.57	0.57	0.36
Financial Leverage	0.84	0.54	0.33	0.14	0.13	0.08	0.00	-0.08	-0.20	-0.23
Leverage Ratio	3.11	3.09	3.28	3.25	3.04	2.63	2.45	2.63	2.48	2.39
Compound Leverage Factor	3.11	3.09	3.28	3.25	3.04	2.63	2.45	2.63	2.48	2.39
Debt to Total Capital	53.57%	47.55%	51.86%	55.16%	46.43%	46.43%	26.88%	36.17%	37.26%	26.61%
Short-Term Debt to Total Capital	0.83%	4.50%	0.80%	4.65%	0.12%	0.03%	1.46%	0.00%	1.82%	0.06%
Long-Term Debt to Total Capital	52.74%	43.06%	51.06%	50.51%	46.31%	46.41%	25.43%	36.17%	35.45%	26.55%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.87%	1.34%	0.77%	0.59%	0.72%	1.79%	2.45%	0.70%	0.61%	0.68%
Common Equity to Total Capital	45.56%	51.11%	47.38%	44.25%	52.85%	51.77%	70.67%	63.13%	62.13%	72.70%
Debt to EBITDA	5.36	1.94	2.43	2.76	2.76	2.28	1.10	1.59	1.78	1.47
Net Debt to EBITDA	4.89	1.20	1.14	0.34	0.37	0.36	0.06	-0.09	-0.38	-1.12
Long-Term Debt to EBITDA	5.28	1.76	2.39	2.53	2.75	2.28	1.04	1.59	1.69	1.46
Debt to NOPAT	14.82	3.74	3.92	4.53	4.76	3.83	1.76	4.66	2.60	2.23
Net Debt to NOPAT	13.52	2.32	1.84	0.56	0.64	0.60	0.10	-0.26	-0.56	-1.70
Long-Term Debt to NOPAT	14.59	3.39	3.86	4.15	4.75	3.83	1.66	4.66	2.48	2.22
Altman Z-Score	2.77	4.30	4.64	5.11	4.36	5.51	4.68	5.01	4.18	4.64
Noncontrolling Interest Sharing Ratio	2.17%	2.13%	1.46%	1.33%	2.33%	3.35%	2.36%	1.04%	0.95%	0.84%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.60	1.80	2.31	2.63	2.43	2.78	2.18	2.59	2.43	2.22
Quick Ratio	0.58	0.82	1.22	1.69	1.35	1.62	1.13	1.45	1.42	1.27
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,378	-159	-144	131	157	92	-42	-16	84	218
Operating Cash Flow to CapEx	220.05%	365.45%	237.99%	324.23%	342.47%	344.19%	491.19%	479.50%	363.33%	688.29%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.67	0.75	0.70	0.72	0.68	1.69	0.93	0.94	0.91	0.90
Accounts Receivable Turnover	6.37	6.15	5.69	6.43	5.70	11.52	5.60	6.27	6.73	6.15
Inventory Turnover	1.69	1.64	1.62	1.72	1.65	3.97	2.00	2.05	2.01	2.04
Fixed Asset Turnover	5.31	5.46	5.67	6.03	5.67	14.38	7.06	6.99	6.85	6.75
Accounts Payable Turnover	7.86	7.62	7.52	8.57	8.28	19.33	10.20	10.74	10.95	12.36
Days Sales Outstanding (DSO)	57.33	59.39	64.15	56.78	64.05	31.67	65.13	58.20	54.21	59.33
Days Inventory Outstanding (DIO)	216.43	222.39	224.99	211.82	221.14	92.05	182.54	178.02	181.74	179.35
Days Payable Outstanding (DPO)	46.43	47.93	48.54	42.59	44.07	18.88	35.80	33.99	33.34	29.53
Cash Conversion Cycle (CCC)	227.33	233.85	240.60	226.00	241.11	104.85	211.87	202.24	202.61	209.15
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,726	2,207	1,706	1,251	1,087	1,067	946	710	605	530
Invested Capital Turnover	1.13	1.52	1.71	2.07	1.85	4.12	2.29	2.69	2.84	2.80
Increase / (Decrease) in Invested Capital	1,520	501	455	164	20	120	237	105	74	-99
Enterprise Value (EV)	10,832	10,970	10,586	12,812	8,335	7,906	4,633	5,208	3,223	3,742
Market Capitalization	8,887	10,141	9,994	12,631	8,209	7,747	4,583	5,224	3,305	3,938
Book Value per Share	$11.75	$9.95	$7.57	$7.06	$6.28	$5.89	$5.73	$4.66	$4.28	$4.33
Tangible Book Value per Share	($4.21)	$3.35	$2.62	$3.42	$2.69	$2.47	$2.57	$3.04	$3.03	$3.10
Total Capital	3,910	2,695	2,351	2,419	1,819	1,752	1,269	1,149	1,105	999
Total Debt	2,094	1,282	1,219	1,334	845	813	341	416	412	266
Total Long-Term Debt	2,062	1,160	1,201	1,222	842	813	323	416	392	265
Net Debt	1,911	793	574	166	113	128	19	-24	-89	-203
Capital Expenditures (CapEx)	114	96	115	87	97	62	49	32	36	33
Debt-free, Cash-free Net Working Capital (DFCFNWC)	621	595	572	478	404	466	401	395	271	209
Debt-free Net Working Capital (DFNWC)	804	1,083	1,218	1,646	1,135	1,151	724	834	771	678
Net Working Capital (NWC)	772	962	1,199	1,533	1,133	1,151	705	834	751	677
Net Nonoperating Expense (NNE)	27	-86	13	14	16	14	13	8.81	3.65	15
Net Nonoperating Obligations (NNO)	1,911	793	574	166	113	128	19	-24	-89	-203
Total Depreciation and Amortization (D&A)	184	115	89	89	80	76	65	64	54	53
Debt-free, Cash-free Net Working Capital to Revenue	18.45%	20.07%	22.61%	19.75%	20.30%	11.25%	21.16%	22.37%	16.82%	12.89%
Debt-free Net Working Capital to Revenue	23.90%	36.54%	48.11%	68.06%	57.12%	27.77%	38.17%	47.25%	47.87%	41.73%
Net Working Capital to Revenue	22.93%	32.45%	47.37%	63.41%	57.01%	27.76%	37.19%	47.25%	46.62%	41.69%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.76	$2.92	$2.00	$1.83	$1.03	$1.27	$1.15	$0.50	$0.95	$0.60
Adjusted Weighted Average Basic Shares Outstanding	149M	146.40M	148.60M	151.40M	153.40M	155.20M	156.20M	158.10M	161.40M	168.20M
Adjusted Diluted Earnings per Share	$0.76	$2.90	$1.99	$1.81	$1.02	$1.26	$1.14	$0.49	$0.95	$0.60
Adjusted Weighted Average Diluted Shares Outstanding	149.50M	147.20M	149.40M	152.90M	154.60M	156.60M	157.20M	159.10M	162.20M	169.10M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$1.27	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	151.71M	137.67M	146.73M	150.77M	151.57M	155.30M	156.74M	156.01M	159.88M	163.42M
Normalized Net Operating Profit after Tax (NOPAT)	212	383	332	305	195	217	209	167	181	140
Normalized NOPAT Margin	6.29%	12.93%	13.13%	12.61%	9.83%	5.24%	11.00%	9.48%	11.21%	8.62%
Pre Tax Income Margin	6.15%	18.36%	16.36%	16.28%	11.36%	6.76%	12.91%	11.20%	11.02%	7.88%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	39.46%	6.16%	13.94%	8.62%	15.99%	12.63%	14.36%	32.88%	17.15%	1.24%
Augmented Payout Ratio	39.46%	41.70%	102.08%	63.26%	92.32%	84.49%	14.36%	222.42%	120.71%	87.04%

This table displays calculated financial ratios and metrics derived from Bruker's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	11.04%	14.64%	16.37%	17.42%	5.31%	20.62%	16.26%	15.89%	15.18%	3.64%	4.93%
EBITDA Growth	-28.97%	-60.82%	-27.09%	-33.17%	-19.29%	91.20%	-2.99%	13.38%	13.83%	2.11%	14.73%
EBIT Growth	-64.94%	-76.71%	-53.61%	-69.16%	-32.83%	99.09%	-7.81%	11.35%	13.40%	1.26%	18.84%
NOPAT Growth	-55.68%	-77.40%	-45.98%	-75.50%	-46.90%	-17.13%	3.21%	21.41%	38.48%	32.49%	-2.40%
Net Income Growth	-67.69%	-93.21%	-54.57%	-86.85%	-32.82%	108.14%	0.34%	16.30%	24.64%	29.34%	0.34%
EPS Growth	-68.57%	-93.53%	-55.00%	-87.18%	-32.69%	110.61%	1.69%	18.18%	26.83%	34.69%	3.51%
Operating Cash Flow Growth	198.17%	-7.54%	-12.93%	-91.54%	-75.09%	19.83%	-36.55%	129.28%	12.47%	23.74%	190.80%
Free Cash Flow Firm Growth	-111.69%	-262.76%	-249.85%	-350.33%	-44.55%	-18.45%	-263.81%	-58.83%	-92.68%	-315.28%	-821.42%
Invested Capital Growth	51.89%	68.87%	90.09%	97.45%	35.14%	29.38%	41.78%	32.94%	37.63%	36.35%	18.78%
Revenue Q/Q Growth	-18.19%	13.33%	7.96%	10.95%	-15.54%	15.04%	8.93%	-0.50%	-3.26%	10.88%	8.58%
EBITDA Q/Q Growth	-30.73%	2.54%	53.84%	-35.00%	-61.79%	90.81%	41.01%	-21.49%	-9.48%	-3.19%	64.80%
EBIT Q/Q Growth	-55.26%	1.45%	131.38%	-66.62%	-70.28%	102.10%	53.81%	-27.30%	-11.90%	-6.42%	85.78%
NOPAT Q/Q Growth	4.98%	-60.32%	217.71%	-66.52%	-46.46%	-5.17%	44.12%	-27.43%	-16.45%	18.11%	69.53%
Net Income Q/Q Growth	20.86%	-65.51%	430.26%	-85.38%	-74.58%	130.67%	53.46%	-25.32%	-21.26%	11.20%	77.87%
EPS Q/Q Growth	22.22%	-66.67%	440.00%	-85.71%	-74.82%	131.67%	53.85%	-25.00%	-21.21%	11.86%	78.79%
Operating Cash Flow Q/Q Growth	-65.79%	394.79%	3,390.91%	-94.95%	-89.39%	365.99%	239.23%	-85.14%	-48.98%	146.76%	256.53%
Free Cash Flow Firm Q/Q Growth	15.27%	18.59%	1.29%	-210.88%	-45.20%	21.48%	-27.06%	0.21%	-18.99%	-141.15%	44.53%
Invested Capital Q/Q Growth	1.47%	-6.67%	4.70%	53.19%	12.81%	5.06%	8.75%	4.84%	8.00%	15.14%	1.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	48.81%	50.36%	48.45%	48.03%	48.88%	50.36%	51.53%	49.93%	52.49%	51.65%	52.48%
EBITDA Margin	9.42%	11.13%	12.30%	8.63%	14.73%	32.56%	19.63%	15.16%	19.22%	20.54%	23.52%
Operating Margin	3.97%	7.36%	7.88%	6.01%	8.98%	12.11%	16.76%	12.64%	17.90%	18.49%	20.55%
EBIT Margin	3.13%	5.73%	6.40%	2.98%	9.92%	28.19%	16.05%	11.37%	15.56%	17.08%	20.24%
Profit (Net Income) Margin	2.10%	1.42%	4.66%	0.95%	7.21%	23.94%	11.94%	8.48%	11.29%	13.88%	13.84%
Tax Burden Percent	66.93%	24.78%	72.88%	31.80%	72.63%	84.93%	74.41%	74.58%	72.61%	81.24%	68.37%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	34.66%	72.55%	26.76%	67.36%	27.65%	15.40%	25.84%	25.68%	28.05%	19.34%	31.86%
Return on Invested Capital (ROIC)	2.85%	2.29%	6.14%	2.13%	9.00%	15.53%	19.56%	15.07%	21.23%	25.54%	25.72%
ROIC Less NNEP Spread (ROIC-NNEP)	2.58%	1.86%	5.50%	1.52%	9.61%	32.66%	19.04%	13.96%	18.90%	23.55%	25.41%
Return on Net Nonoperating Assets (RNNOA)	2.32%	1.56%	5.36%	1.31%	6.03%	17.54%	11.98%	7.01%	7.83%	7.86%	8.51%
Return on Equity (ROE)	5.17%	3.85%	11.50%	3.44%	15.03%	33.07%	31.55%	22.08%	29.06%	33.40%	34.24%
Cash Return on Invested Capital (CROIC)	-37.69%	-46.47%	-54.87%	-56.36%	-16.08%	-8.11%	-14.98%	-7.77%	-10.55%	-9.72%	3.78%
Operating Return on Assets (OROA)	2.07%	3.83%	4.18%	1.91%	7.20%	21.26%	12.64%	8.52%	11.15%	11.91%	15.69%
Return on Assets (ROA)	1.38%	0.95%	3.04%	0.61%	5.23%	18.06%	9.41%	6.35%	8.09%	9.67%	10.73%
Return on Common Equity (ROCE)	2.22%	3.76%	11.23%	3.36%	14.66%	32.37%	30.80%	21.57%	28.39%	32.91%	33.72%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	16.85%	19.72%	28.48%	0.00%	26.65%	26.15%	26.59%	0.00%	29.48%
Net Operating Profit after Tax (NOPAT)	21	20	50	16	47	88	92	64	88	106	89
NOPAT Margin	2.59%	2.02%	5.77%	1.96%	6.50%	10.25%	12.43%	9.40%	12.88%	14.92%	14.00%
Net Nonoperating Expense Percent (NNEP)	0.27%	0.44%	0.64%	0.61%	-0.61%	-17.12%	0.52%	1.11%	2.34%	1.99%	0.31%
Return On Investment Capital (ROIC_SIMPLE)	0.53%	0.51%	-	-	-	3.27%	-	-	-	4.51%	-
Cost of Revenue to Revenue	51.19%	49.64%	51.55%	51.97%	51.12%	49.64%	48.47%	50.07%	47.51%	48.35%	47.52%
SG&A Expenses to Revenue	28.13%	25.25%	26.60%	27.64%	27.06%	24.72%	23.91%	26.09%	23.74%	23.25%	22.66%
R&D to Revenue	12.12%	10.66%	11.35%	11.51%	11.33%	9.77%	9.60%	10.41%	10.07%	8.96%	8.80%
Operating Expenses to Revenue	44.85%	43.00%	40.57%	42.03%	39.91%	38.24%	34.77%	37.29%	34.58%	33.16%	31.93%
Earnings before Interest and Taxes (EBIT)	25	56	55	24	72	241	119	78	107	121	129
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	76	109	106	69	106	278	146	103	132	146	150
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	4.99	5.79	5.18	9.13	7.36	7.55	8.78	9.77	8.97	8.35
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	60.33	21.85	25.64	29.00	32.52	25.94	22.90
Price to Revenue (P/Rev)	1.84	2.64	3.23	2.97	4.31	3.42	3.24	3.98	4.40	3.95	3.12
Price to Earnings (P/E)	79.55	78.57	34.29	26.34	32.18	23.74	28.59	33.89	37.00	33.70	28.45
Dividend Yield	0.48%	0.34%	0.29%	0.31%	0.21%	0.27%	0.32%	0.27%	0.25%	0.29%	0.36%
Earnings Yield	1.26%	1.27%	2.92%	3.80%	3.11%	4.21%	3.50%	2.95%	2.70%	2.97%	3.52%
Enterprise Value to Invested Capital (EV/IC)	2.19	2.91	3.17	2.96	5.62	4.97	4.77	5.96	6.62	6.21	5.65
Enterprise Value to Revenue (EV/Rev)	2.40	3.22	3.90	3.62	4.66	3.70	3.55	4.24	4.65	4.18	3.34
Enterprise Value to EBITDA (EV/EBITDA)	23.01	27.72	22.58	18.85	22.09	16.64	19.02	21.69	23.50	21.06	16.74
Enterprise Value to EBIT (EV/EBIT)	51.62	52.35	32.27	24.80	27.49	20.16	23.60	26.51	28.58	25.58	20.28
Enterprise Value to NOPAT (EV/NOPAT)	75.33	76.66	57.27	42.92	46.83	32.04	28.57	33.17	36.30	34.04	29.27
Enterprise Value to Operating Cash Flow (EV/OCF)	28.12	43.10	47.38	41.46	49.22	31.33	31.68	33.72	42.90	38.58	34.64
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	162.31
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.14	1.15	1.25	1.18	0.95	0.91	0.98	0.98	1.02	1.08	1.21
Long-Term Debt to Equity	1.12	1.14	1.23	1.17	0.94	0.82	0.88	0.89	0.92	1.06	1.19
Financial Leverage	0.90	0.84	0.97	0.86	0.63	0.54	0.63	0.50	0.41	0.33	0.34
Leverage Ratio	3.16	3.11	3.22	3.16	3.11	3.09	3.26	3.21	3.25	3.28	3.16
Compound Leverage Factor	3.16	3.11	3.22	3.16	3.11	3.09	3.26	3.21	3.25	3.28	3.16
Debt to Total Capital	53.31%	53.57%	55.49%	54.19%	48.72%	47.55%	49.50%	49.62%	50.38%	51.86%	54.75%
Short-Term Debt to Total Capital	0.95%	0.83%	0.79%	0.66%	0.75%	4.50%	4.91%	4.82%	4.92%	0.80%	0.81%
Long-Term Debt to Total Capital	52.36%	52.74%	54.69%	53.53%	47.97%	43.06%	44.59%	44.79%	45.45%	51.06%	53.94%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.46%	0.87%	0.87%	0.89%	1.25%	1.34%	1.44%	1.25%	1.25%	0.77%	0.79%
Common Equity to Total Capital	0.00%	45.56%	43.64%	44.92%	50.02%	51.11%	49.06%	49.13%	48.37%	47.38%	44.46%
Debt to EBITDA	5.87	5.36	4.10	3.60	2.18	1.94	2.32	2.34	2.37	2.43	2.31
Net Debt to EBITDA	5.36	4.89	3.84	3.32	1.64	1.20	1.63	1.26	1.22	1.14	1.06
Long-Term Debt to EBITDA	5.77	5.28	4.04	3.56	2.14	1.76	2.09	2.11	2.14	2.39	2.28
Debt to NOPAT	19.23	14.82	10.41	8.20	4.61	3.74	3.48	3.58	3.66	3.92	4.04
Net Debt to NOPAT	17.56	13.52	9.74	7.55	3.47	2.32	2.44	1.93	1.88	1.84	1.85
Long-Term Debt to NOPAT	18.89	14.59	10.26	8.10	4.54	3.39	3.13	3.23	3.30	3.86	3.98
Altman Z-Score	1.68	2.69	2.75	2.64	4.25	4.07	3.27	3.62	3.84	4.37	3.27
Noncontrolling Interest Sharing Ratio	57.14%	2.17%	2.32%	2.16%	2.48%	2.13%	2.37%	2.29%	2.29%	1.46%	1.52%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.57	1.60	1.66	1.65	1.81	1.80	1.89	2.08	2.03	2.31	2.36
Quick Ratio	0.54	0.58	0.52	0.52	0.69	0.82	0.79	0.98	1.02	1.22	1.21
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,271	-1,500	-1,842	-1,866	-600	-413	-527	-414	-415	-349	-145
Operating Cash Flow to CapEx	250.00%	520.55%	117.79%	4.55%	104.31%	656.55%	165.17%	55.32%	611.89%	497.10%	120.45%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.66	0.67	0.65	0.64	0.73	0.75	0.79	0.75	0.72	0.70	0.78
Accounts Receivable Turnover	6.80	6.37	6.33	6.51	6.34	6.15	6.22	6.36	5.92	5.69	6.32
Inventory Turnover	1.62	1.69	1.55	1.50	1.56	1.64	1.64	1.57	1.58	1.62	1.65
Fixed Asset Turnover	5.41	5.31	5.31	5.29	5.47	5.46	5.94	5.92	5.73	5.67	6.18
Accounts Payable Turnover	7.93	7.86	8.09	7.67	7.56	7.62	8.07	7.64	7.06	7.52	8.20
Days Sales Outstanding (DSO)	53.66	57.33	57.64	56.04	57.60	59.39	58.71	57.38	61.66	64.15	57.78
Days Inventory Outstanding (DIO)	225.97	216.43	235.61	243.13	234.37	222.39	221.95	232.60	231.21	224.99	220.94
Days Payable Outstanding (DPO)	46.06	46.43	45.11	47.58	48.27	47.93	45.20	47.77	51.69	48.54	44.54
Cash Conversion Cycle (CCC)	233.57	227.33	248.15	251.59	243.70	233.85	235.45	242.21	241.18	240.60	234.19
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,781	3,726	3,992	3,813	2,489	2,207	2,100	1,931	1,842	1,706	1,481
Invested Capital Turnover	1.10	1.13	1.06	1.09	1.39	1.52	1.57	1.60	1.65	1.71	1.84
Increase / (Decrease) in Invested Capital	1,292	1,520	1,892	1,882	647	501	619	479	504	455	234
Enterprise Value (EV)	8,280	10,832	12,641	11,298	13,997	10,970	10,014	11,515	12,189	10,586	8,365
Market Capitalization	6,332	8,887	10,455	9,274	12,923	10,141	9,123	10,815	11,527	9,994	7,821
Book Value per Share	$0.00	$11.75	$11.94	$12.31	$10.28	$9.95	$8.23	$8.39	$8.04	$7.57	$6.33
Tangible Book Value per Share	($16.05)	($4.21)	($4.58)	($4.67)	$1.56	$3.35	$2.42	$2.54	$2.42	$2.62	$2.31
Total Capital	3,965	3,910	4,140	3,983	2,829	2,695	2,464	2,506	2,440	2,351	2,108
Total Debt	2,114	2,094	2,297	2,158	1,379	1,282	1,220	1,243	1,229	1,219	1,154
Total Long-Term Debt	2,076	2,062	2,265	2,132	1,357	1,160	1,099	1,123	1,109	1,201	1,137
Net Debt	1,930	1,911	2,149	1,989	1,038	793	856	669	631	574	528
Capital Expenditures (CapEx)	26	37	33	24	21	31	27	24	14	35	58
Debt-free, Cash-free Net Working Capital (DFCFNWC)	620	621	754	705	639	595	715	679	607	572	563
Debt-free Net Working Capital (DFNWC)	804	804	902	875	979	1,083	1,078	1,253	1,205	1,218	1,189
Net Working Capital (NWC)	767	772	869	849	958	962	957	1,132	1,085	1,199	1,172
Net Nonoperating Expense (NNE)	3.98	5.89	9.57	8.10	-5.12	-117	3.63	6.27	11	7.37	1.06
Net Nonoperating Obligations (NNO)	1,930	1,911	2,149	1,989	1,038	793	856	669	631	574	528
Total Depreciation and Amortization (D&A)	50	53	51	45	35	37	27	26	25	25	21
Debt-free, Cash-free Net Working Capital to Revenue	17.99%	18.45%	23.26%	22.60%	21.29%	20.07%	25.35%	25.00%	23.15%	22.61%	22.46%
Debt-free Net Working Capital to Revenue	23.34%	23.90%	27.83%	28.04%	32.63%	36.54%	38.25%	46.17%	45.96%	48.11%	47.45%
Net Working Capital to Revenue	22.25%	22.93%	26.82%	27.20%	31.92%	32.45%	33.96%	41.72%	41.38%	47.37%	46.77%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.11	$0.09	$0.27	$0.05	$0.35	$1.41	$0.60	$0.39	$0.52	$0.66	$0.60
Adjusted Weighted Average Basic Shares Outstanding	151.60M	149M	151.50M	147.40M	145.20M	146.40M	146.60M	146.80M	146.80M	148.60M	147.80M
Adjusted Diluted Earnings per Share	$0.11	$0.09	$0.27	$0.05	$0.35	$1.39	$0.60	$0.39	$0.52	$0.66	$0.59
Adjusted Weighted Average Diluted Shares Outstanding	151.90M	149.50M	152M	148M	145.90M	147.20M	147.30M	147.70M	147.60M	149.40M	148.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	151.53M	151.71M	151.60M	151.39M	145.34M	137.67M	138.41M	146.85M	146.73M	146.73M	147.08M
Normalized Net Operating Profit after Tax (NOPAT)	45	99	66	50	55	115	99	68	92	111	92
Normalized NOPAT Margin	5.60%	10.12%	7.69%	6.22%	7.59%	13.43%	13.37%	9.98%	13.44%	15.68%	14.32%
Pre Tax Income Margin	3.13%	5.73%	6.40%	2.98%	9.92%	28.19%	16.05%	11.37%	15.56%	17.08%	20.24%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	57.63%	39.46%	10.31%	9.27%	8.06%	6.16%	8.44%	8.98%	11.54%	13.94%	14.12%
Augmented Payout Ratio	70.36%	39.46%	26.86%	46.08%	40.29%	41.70%	48.23%	46.13%	68.87%	102.08%	129.62%

Frequently Asked Questions About Bruker's Financials

When does Bruker's financial year end?

According to the most recent income statement we have on file, Bruker's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Bruker's net income changed over the last 9 years?

Bruker's net income appears to be on an upward trend, with a most recent value of $113.80 million in 2024, rising from $104.90 million in 2015. The previous period was $428.50 million in 2023. Check out Bruker's forecast to explore projected trends and price targets.

What is Bruker's operating income?

Bruker's total operating income in 2024 was $253.10 million, based on the following breakdown:

Total Gross Profit: $1.65 billion
Total Operating Expenses: $1.40 billion

How has Bruker revenue changed over the last 9 years?

Over the last 9 years, Bruker's total revenue changed from $1.62 billion in 2015 to $3.37 billion in 2024, a change of 107.3%.

How much debt does Bruker have?

Bruker's total liabilities were at $3.99 billion at the end of 2024, a 40.7% increase from 2023, and a 300.3% increase since 2015.

How much cash does Bruker have?

In the past 9 years, Bruker's cash and equivalents has ranged from $183.40 million in 2024 to $1.07 billion in 2021, and is currently $183.40 million as of their latest financial filing in 2024.

How has Bruker's book value per share changed over the last 9 years?

Over the last 9 years, Bruker's book value per share changed from 4.33 in 2015 to 11.75 in 2024, a change of 171.7%.

Related Companies

This page (NASDAQ:BRKR) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bruker (BRKR) Financials

Frequently Asked Questions About Bruker's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bruker (BRKR) Financials

Annual Income Statements for Bruker

Quarterly Income Statements for Bruker

Annual Cash Flow Statements for Bruker

Quarterly Cash Flow Statements for Bruker

Annual Balance Sheets for Bruker

Quarterly Balance Sheets for Bruker

Annual Metrics And Ratios for Bruker

Quarterly Metrics And Ratios for Bruker

Frequently Asked Questions About Bruker's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools